| 321 |
HOVID TENOFOVIR DISOPROXIL FUMARATE TABLETS 300 MG |
TENOFOVIR DISOPROXIL FUMARATE 300 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF HIV-1 INFECTION IN COMBINATION WITH OTHER ANTIRETROVIRAL MEDICINAL PRODUCT FOR ADULTS, TREATMENT OF HIV-1 INFECTED ADOLESCENTS WITH NRTI RESISITANCE OR TOXICITIES PRECLUDING THE USE OF FIRST LINE AGENTS, AGED 12 TO <18 YEARS, FORO THE TREATMENT OF CHRONIC HEPATITIS B IN ADULT AND ADOLESCENT 12 - <18 YEARS OF AGE. |
Yes |
BMS PHARMA SOLE CO.,LTD |
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO.,LTD |
CHINA |
CERTIFICATE RELEASED |
01 I 5391/23 |
2023-01-23 |
2026-01-22 |
View |
| 322 |
HOVID-XYFISIM CAPSULE 200 MG |
CEFIXIME 200 MG |
CAPSULE |
PVC/ALU BLISTERPACK |
UPPER AND LOWER RESPIRATORY TRACT INFECTION, URINARY TRACT INFECTION |
Yes |
BMS PHARMA SOLE CO.,LTD |
SINOPHARM ZHIJUN(SHENZHEN) PHARMACEUTICAL CO.,LTD |
CHINA |
CERTIFICATE RELEASED |
04 I 5728/24 |
26/4/2024 |
25/4/2027 |
View |
| 323 |
KETOCONAZOLE TABLET 200 MG |
KETOCONAZOLE 200 MG |
TABLET |
BLISTERPACK |
TREATMENT OF THE FOLLOWING SYSTEMIC FUNGAL INFECTIONS IN PATIENTS WHO HAVE FAILED OR WHO ARE INTOLERANT TO OTHER THERAPIES:BLASTOMYCOSIS, COCCIDIOIDOMYCOSIS, HISTOPLASMOSIS, CHROMOMYCOSIS AND PARACOCCIDIOIDOMYCOSIS |
Yes |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
05 I 4705/19 |
2022-09-08 |
2025-09-07 |
View |
| 324 |
KETOFEN |
KETOPROFEN 2.5% W/W |
GEL |
Tube |
KETOPROFEN GEL IS INDICATED FOR INFLAMMATORY NON - ARTICULAR MUSCULOSKELETAL CONDITIONS AND MILD TRAUMA DUE TO SPORTS INJURIES, SPRAINS, TENDONITIS, MUSCULOTENDINOUS CONFUSION AND OEDEMA. |
No |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
02 I 4212/17 |
2023-06-07 |
2026-06-06 |
View |
| 325 |
KETOVID CREAM 2% |
KETOCONAZOLE MICRONISED 2% W/W |
CREAM |
TUBE |
TREATMENT OF DERMATOPHYTE INFECTIONS OF THE SKIN - TINEA CORPORIS, TINEA CRURIS TINEA MANUS AND TINEA PEDIS CAUSE BY TRICHOPHYTON RUBRUM, TREATMENT OF CUTANEOUS CANDIDIASIS, PITYRIASIS VERSICOLOR AND SEBORRHOEIC DERMATITIS. |
Yes |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
09 I 4173/16 |
2023-06-07 |
2026-06-06 |
View |
| 326 |
KETOVID SHAMPOO 2% W/W |
KETOCONAZOLE 2% W/W |
LIQUID |
BOTTLE |
TREATMENT AND PROPHYLAXIS OF INFECTIONS IN WHICH THE YEAST MALASSEZIA IS INVOLVED, SUCH AS PITYRIASIS VERICOLOR( LOCALISED), SEBORRHOEIC DERMATITIS AND PITYRIASIS CAPITIS (DANDRUFF). |
Yes |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
06 I 4042/15 |
09-ม.ค.-2025 |
08-ม.ค.-2030 |
View |
| 327 |
LIPIDUCE-10 |
ATORVASTATIN CALCIUM 11.02 MG EQ.TO ATORVASTATIN 10 MG |
TABLET |
BLISTERPACK |
AS AN ADJUNCT THERAPY TO DIET TO REDUCE ELEVATED TOTAL, LDL-CHOLESTEROL, APOLIPOPROTEINE B, TRIGLYCERIDES AND INCREASE HDL-CHOLESTEROL IN PATIENT WITH PRIMARY HYPERCHOLESTEROLEMIA ( HETEROZYGOUS FAMILIAL AND NONFAMILIAL), COMBINED HYPERLIPIDEMIA (FREDRICKSON TYPES IIA AND IIB), PRIMARY DYSETALIPOPROTEINEMIA |
Yes |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
04 I 4688/19 |
2022-09-08 |
2025-09-07 |
View |
| 328 |
LIPIDUCE-20 |
ATORVASTATIN CALCIUM 21.70 MG EQ.TO ATORVASTATIN 20 MG |
TABLET |
BLISTERPACK |
AS AN ADJUNCT THERAPY TO DIET TO REDUCE ELEVATED TOTAL, LDL-CHOLESTEROL, APOLIPOPROTEINE B, TRIGLYCERIDES AND INCREASE HDL-CHOLESTEROL IN PATIENT WITH PRIMARY HYPERCHOLESTEROLEMIA ( HETEROZYGOUS FAMILIAL AND NONFAMILIAL), COMBINED HYPERLIPIDEMIA (FREDRICKSON TYPES IIA AND IIB), PRIMARY DYSETALIPOPROTEINEMIA |
Yes |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
04 I 4689/19 |
2022-09-08 |
2025-09-07 |
View |
| 329 |
METHACIN |
INDOMETHACIN 25 MG |
CAPSULE |
BLISTERPACK |
FOR TREATMENT OF RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS, OSTEOARTHRITIS, OTHER RHEUMATIC DISORDERS AND ACUTE GOUT |
No |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
06 I 4043/15 |
2022-05-30 |
2025-05-29 |
View |
| 330 |
MONTELAIR 10 |
MONTELUKAST SODIUM 10.40 MG EQ.TO MONTELUKAST10 MG |
TABLET |
BLISTERPACK |
FOR THE PROPHYLAXIS AND CHRONIC TREATMENT OF ASTHMA IN ADULTS. IN ADULTS 15 YEARS AGE AND OLDER FOR THE RELIEF OF DAYTIME AND NIGHTTIME SYMPTOMS OF SEASONAL ALLERGIC RHINITIS |
Yes |
BMS PHARMA SOLE CO.,LTD |
HOVID BHD |
MALAYSIA |
CERTIFICATE RELEASED |
04 I 4912/20 |
2023-06-07 |
2026-06-06 |
View |
